Modern, nobel-prize winning research shows that hardly any traditional investment funds are adding any value beyond what fully automated strategies can do. NorQuant's mission is to help private and professional investors achieve higher returns at lower costs through a scientific, rules-based, 100% transparent approach. We feel we are off to a good start: - We are helping our first pilot customer, one of Norway's largest family offices, implement factor-based analysis - We have been selected as one of ten fintech-startups for TheFactory.no Fall18 program, out of more than 200 applications

We develop business with positive impact on the environment and society – creating more with less based on game changing new technologies. Our ambition is to create synergies of resources available, from the Earth, from research and between people and networks. Therefore, we have chosen Vili Vé as our name, from the two brothers of Odin who created fjords and mountains out of the resources available from Ymir. Our focus areas are cleantech and life science, our primary market is Europe and Asia, our customers and partners are major manufacturers, distributors, B2B customers and consulting companies. Our team, communication and style reflects diversity and openness, and our teamwork is based on dedication and trust. We want our customers and partners to experience us as competent, genuine and attentive – and proactively focusing on win-win solutions.

Nøtteblanderen er en lokal matprodusent som produserer og pakker produkter av ypperste kvalitet innen nøtter, frukt, frø, ris, bønner, kokos, krydder, urter, sjokolade, snacks og te. Nøtteblanderen har et moderne produksjonsanlegg på Helsfyr/Ensjø i Oslo som benytter utelukket norsk arbeidskraft som gir lokale arbeidsplasser i Norge.

UpStacked is the All-in-One centralized operations platform that crushes SLA requirements to increase profitability and reduce OPEX. Purpose-built for internal IT and MSPs to operate SMBs and Enterprises. With user experience in mind, UpStacked drives complex to zero-touch, through automation and machine learning. UpStacked at a Glance: - All-in-One Centralized Platform - Enterprise onboarding in minutes - Third-Party integrations - Zero-Touch - Simplified License Management - Real-Time On-Demand Reporting - Real-Time Topology Based Correlation - Real-Time Event-Based Correlation - Built-in Role Based Access Control - Natively Multi-Tenant - Multi-Vendor - ITIL

Get your products from the manufacturer to the end customer in the fastest and easiest way possible. Regardless of existing volume or size - NBS provides you with the sales channels, systems, and logistics to reach the whole of Norway. IT-system One system for product registration, sales, statistics, and inventory for your products. Fully integrated with all the services you need. Logistics Efficient logistics from a central warehouse in Vestby of 5,500 m2 specially built for handling beverages. Sales to all channels Sell ​​your products under 4.7% alcohol to private customers through Lokalbrygg.no, over 4.7% alcohol to Vinmonopolet, and everything to HoReCa through horecalevering.no. Marketing and Fairs Increase your visibility through our own fairs for HoReCa, private customers, and Vinmonopolet.

Otivio’s main product, FlowOx™, is addressing chronic wounds with focus on peripheral arterial disease (PAD), which is a serious condition leading to pain, chronic wounds and in many cases amputation and mortality. The patient population is very large and increasing. There are limited adequate treatment options offered to the patients aside from surgical interventions. FlowOx™ is a non-invasive product intended for home use. Long-term patient testing in more than 50 patients documents increased blood flow, reduced pain and wound healing. FlowOx™ is CE marked. In fourth quarter 2017 had its commercial break-through through sales of FlowOx to public customers.

Oncoinvent AS is a privately held Norwegian company established in 2010. The company is committed to developing new innovative products to provide better treatment options to cancer patients. The innovations being developed by Oncoinvent AS are a result of the extensive experience with the development of radionuclide-based cancer treatments of two of the founders, Dr. Roy H. Larsen and Professor of clinical oncology Øyvind S. Bruland. Larsen and Bruland are the inventors of the first FDA and EMA-approved alpha-emitting pharmaceutical product Xofigo® (Bayer AG), as well as of the beta-emitting radio-immunotherapeutic product candidate Betalutin® (Nordic Nanovector ASA). Oncoinvent's lead product candidate, Radspherin®, is a novel alpha-emitting radioactive microsphere designed for the treatment of metastatic cancers in body cavities. Radspherin® has been shown to cause a significant reduction in tumor cell growth. It is anticipated that the product can potentially treat several forms of metastatic cancer. The first clinical indication for Radspherin® will be the treatment of peritoneal carcinomatosis. Clinical development will be conducted in collaboration with European and American clinical research centers.

Yetz is a new distribution platform for product lines such as insurance, electricity, telecom, and finance. At launch, we will offer both insurance and power. We utilize strong incentives towards our customers and partners to share the concept, by giving them an affiliate commission. Monthly payment is based on the turnover of customers they have referred. Two fully owned sister companies Yetz Strøm og Yetz Forsikring.

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.

LangO is changing the way companies deliver English language training to their employees online. We do this through a blended learning solution; a combination of live virtual lessons (Group Live Lessons and One-to-One) complemented by our on-demand micro-learning activities. Our responsive web app brings in the best-qualified teachers from around the world, custom-made LangO lesson content based on client's needs, and a scalable tech stack enabling employees to learn effectively on any device, at any time.

BRIK as is a company specialising in new web technology, pedagogy and professional dissemination of knowledge. The team has extensive experience in the dissemination of knowledge with new web technologies and video. Our investors and partners are Innovation Norway, the Norwegian Research Council and several customer partners. The budget for the initial development phase (2013 - ) has been 12 MNOK. Now we are looking for partners for the next stage, where we will commercialize and increase sales.

“SevenSix is a learning and development platform to empower tennis players through their careers. It will be a holistic service, transforming data into knowledge about strengths and opportunities, to optimize how the player exercises, competes, eats, sleeps, thinks and is motivated. This is done by gathering, transforming, combining, and visualizing ALL relevant data, bridging science and technology combined with methodology and experience. ”MVBP is ready and is beeing tested on the national team of tennis and Stavanger Tennisklubb. The development is supported by Microsoft and Capgemini.SevenSix will be distributed to 100 million tennis players with membership in Tennis Federations.

"Transparently Norwegian"​ We carefully select guaranteed Norwegian products, ship them via our own "digital highway of trust"​ to ourselves (in China) and sell them directly to end-users in the world (starting with China) through our own e-Commerce platform (and soon in our own retail stores). We are in business, we control the whole value chain, we do it differently and our concept can't be copied by big American tech or food companies. We also represent business opportunities for other companies.

Nordic Unmanned is one of the world’s leading suppliers of drones and data capture solutions. With our wide customer base and extensive experience, we’re able to provide our clients with high-end products and services that meet their specific needs. Our goal is to help our clients achieve their desired outcomes through the use of unmanned systems and services, making them more efficient, effective, and profitable. We are continuously looking for talent, and we recommend any individual that might be interested in working at Nordic Unmanned, to either apply for one of our vacant positions or create a profile at https://jobs.nordicunmanned.com/

Norwegian wearable company that specializes in payments using tokenization technology through NFC. Berg is the first company to deliver classic watches to the market that customers can pay with and more. We are currently looking for strategic investors that can help us bring our products to the masses. Contact our CEO, Paal Friele Grung through paal@bergwatches.com for more.